Financials

Ingresos totales
Beneficio neto
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.12
Relación precio/flujo de caja
58.78

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4527
COCP
Cocrystal Pharma, Inc. - Common Stock
1.12 USD-3.45%-0.88%+28.74%-27.74%21.57 M USD
4529
LGVN
Longeveron Inc. - Class A Common stock
6.75 USD-2.17%+878.26%+850.70%+1081.52%21.52 M USD
4542
KZIA
Kazia Therapeutics Limited - American Depositary Shares
12.63 USD-8.28%-8.41%-1.33%+115.90%20.45 M USD
4544
NEUP
Neuphoria Therapeutics Inc. - Common Stock
3.79 USD+0.80%-1.81%-1.81%-66.55%20.48 M USD

Noticias